COMMUNIQUÉS West-GlobeNewswire

MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023
25/06/2024
TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F [...]
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
25/06/2024
HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]
Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing Clearance
25/06/2024
Twelve Required Registration Batches Completed New Drug Application Being Prepped for Submission KANSAS CITY, Kan., June 25, 2024 (GLOBE NEWSWIRE) -- In alignment with U.S. Food and Drug Administration (FDA) [...]
InkSpace Imaging Broadens Body Array Access Across GE HealthCare 3T MRI Systems
25/06/2024
PLEASANTON, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging proudly announces that GE Healthcare has certified their Snuggle™ and Silhouette™ MRI body arrays. They are now compatible with GE HealthCare Signa [...]
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation
25/06/2024
Report highlights key progress and achievements across three pillars: access to medicines, R&D innovation, and product quality and patient safety 430,000 patients have been treated with Samsung Bioepis’ biosimilars [...]
Shape Therapeutics Appoints Healthcare Industry Leaders David Epstein and Todd Simpson to its Board of Directors
25/06/2024
Epstein and Simpson bring significant life sciences industry expertise that will be integral to the Company’s continued growth as a leader in AI for genomic medicine SEATTLE, June 25, 2024 (GLOBE NEWSWIRE) -- Shape [...]
Privia Receives HFMA’s MAP Award for High Performance in Revenue Cycle for Performance Year 2023
25/06/2024
Privia Health has received the HFMA MAP Award in eight of the past nine years ARLINGTON, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical [...]
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
25/06/2024
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne [...]
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
25/06/2024
LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a [...]
Safety Shot Announces Strategic Partnership with Chip Quigley and Ari Freedman
25/06/2024
The Executives Will Support the Company with Deep Expertise Across Entertainment, Development and Distribution JUPITER, FL, June 25, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) proudly announces today a [...]
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
25/06/2024
First Commercial Agreement for DispersinB® WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide [...]
Oragenics, Inc. Announces Pricing of Public Offering
25/06/2024
SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced [...]
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
25/06/2024
Established in 1932, the London Clinic is the UK’s Most Renowned Independent, Private Hospital Payment to Aclarion for Each Nociscan is Being Increased From the Original Contract Contract Extension Aligns Aclarion and [...]
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
25/06/2024
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
25/06/2024
The pooled analysis included data from 4 i nternational clinical trials spanning a n array of hard-to-treat indications including skin, head & neck, and oral cavity. Initial response data demonstrated an overall [...]
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
25/06/2024
Funding of $1.49 million USD to support the development of KLS-13019 targeting neuroinflammation and mitochondrial dysfunction Kannalife has developed a new class of orally bioavailable drugs to address [...]
Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
25/06/2024
NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics , a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC) therapeutics, today [...]
BrightSpring Health Services Announces Definitive Agreement to Acquire Haven, Expanding Its Hospice Services into the CON State of Florida
24/06/2024
LOUISVILLE, Ky., June 24, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, [...]
Data from Phase 2 ACcomplisH Trial of TransCon CNP in Children with Achondroplasia Presented at ICCHBH 2024
24/06/2024
• Data demonstrate significant improvements in well-being and physical functioning compared to placebo in patients treated for 1 year with TransCon CNP at the pivotal 100μg/kg/week dose • Improvements could not be [...]

Pages